Scholtz & Company, LLC Insulet Corp Transaction History
Scholtz & Company, LLC
- $224 Million
- Q3 2025
A detailed history of Scholtz & Company, LLC transactions in Insulet Corp stock. As of the latest transaction made, Scholtz & Company, LLC holds 11,258 shares of PODD stock, worth $3.75 Million. This represents 1.55% of its overall portfolio holdings.
Number of Shares
11,258
Previous 9,346
20.46%
Holding current value
$3.75 Million
Previous $2.94 Million
18.36%
% of portfolio
1.55%
Previous 1.31%
Shares
6 transactions
Others Institutions Holding PODD
# of Institutions
909Shares Held
60.3MCall Options Held
325KPut Options Held
557K-
Vanguard Group Inc Valley Forge, PA8.8MShares$2.93 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$2.02 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.55MShares$1.51 Billion0.28% of portfolio
-
State Street Corp Boston, MA3.09MShares$1.03 Billion0.03% of portfolio
-
Baillie Gifford & CO2.09MShares$696 Million0.5% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $23.1B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...